Podcast appearances and mentions of Robert H Lurie

Nicole Bronson v. Ann & Robert H. Lurie Children

A breathtaking one in five people in the U.S. has a health condition related to food—from disruptive sensitivities and intolerances to serious allergic reactions that can send them to the ER.A breathtaking one in five people in the U.S. has a health condition related to food—from disruptive sensitivities and intolerances to serious allergic reactions that can send them to the ER.These food-related problems are on a historic rise across all ages. And the spectrum of these ailments is wide and deep, with many tricky “masqueraders” in the mix to create a lot of confusion, potential misdiagnoses, and faulty or poor treatment—and immeasurable suffering for millions of people. The good news: Dr. Ruchi Gupta, on the front lines of this silent epidemic, now shares revolutionary research from her lab and clinical practice.In her latest book Food Without Fear, Dr. Gupta illuminates this misunderstood spectrum and offers a new approach to managing adverse reactions to food with a practical plan to end the misery and enjoy eating with ease.Ruchi Gupta, MD, MPH, is a professor of pediatrics and medicine at Northwestern University Feinberg School of Medicine and a clinical attending at Ann & Robert H. Lurie Children's Hospital of Chicago. Dr. Gupta has more than 17 years of experience as a board-certified pediatrician and health researcher and currently serves as the founding director of the Center for Food Allergy & Asthma Research (CFAAR), and is world-renowned for her groundbreaking research in the areas of food allergy and asthma epidemiology, most notably for her research on the prevalence of pediatric and adult food allergy in the United States.

A breathtaking one in five people in the U.S. has a health condition related to food—from disruptive sensitivities and intolerances to serious allergic reactions that can send them to the ER.A breathtaking one in five people in the U.S. has a health condition related to food—from disruptive sensitivities and intolerances to serious allergic reactions that can send them to the ER.These food-related problems are on a historic rise across all ages. And the spectrum of these ailments is wide and deep, with many tricky “masqueraders” in the mix to create a lot of confusion, potential misdiagnoses, and faulty or poor treatment—and immeasurable suffering for millions of people. The good news: Dr. Ruchi Gupta, on the front lines of this silent epidemic, now shares revolutionary research from her lab and clinical practice.In her latest book Food Without Fear, Dr. Gupta illuminates this misunderstood spectrum and offers a new approach to managing adverse reactions to food with a practical plan to end the misery and enjoy eating with ease.Ruchi Gupta, MD, MPH, is a professor of pediatrics and medicine at Northwestern University Feinberg School of Medicine and a clinical attending at Ann & Robert H. Lurie Children's Hospital of Chicago. Dr. Gupta has more than 17 years of experience as a board-certified pediatrician and health researcher and currently serves as the founding director of the Center for Food Allergy & Asthma Research (CFAAR), and is world-renowned for her groundbreaking research in the areas of food allergy and asthma epidemiology, most notably for her research on the prevalence of pediatric and adult food allergy in the United States.

What questions are you trying to answer for your health system. Here are the questions five current CIOs have prioritized for their health systems.FTALisa Dykstra CIO of Ann & Robert H. Lurie Children's Hospital of Chicago- As the role of the CIO continues to expand and grow in complexity, how are you preparing your teams and organizations for the future of healthcare?BJ Moore CIO of Providence- How do we continue accelerating the adoption of advanced technologies (such as machine learning, artificial intelligence, big data or Internet of Things) for patient outcomes and caregiver productivity and build upon modern hybrid workplace momentum in a way that supports organizational resilience, innovation and a strong culture?Manu Tandon CIO Beth Israel Deaconess Medical CenterIs it time to expedite the adoption of the public cloud for healthcare providers?Ryan Smith CIO Intermountain HealthcareHow will we provide an equitable experience to all employees in a new, hybrid work environment?Ellen Pollack Interim CIO UCLA HealthHow can IT best support a COVID-19-fatigued workforce?----Clarifying and asking the right questions is a great strategic exercise. These CIOs pose great questions and I hope we will see some great progress in these areas..#healthcare #cio #cmio #healthIT #chime #himsshttps://www.beckershospitalreview.com/healthcare-information-technology/5-questions-hospital-cios-need-answered-why.html

Meet the CIO of the Year® ORBIE® Finalists for the National ORBIE® Awards, held July 22nd, 2021.Mamatha Chamarthi, StellantisSeemantini Godbole, Lowe'sJennifer Hartsock, Baker HughesMax Chan, Avnet IncSteve Hagood, Trane TechnologiesMona Bates, Raytheon Technologies - Missiles & DefenseDave, Duvall, Discovery, Inc.Donie Lochan, InvescoBarry Shurkey, NTT Data ServicesAdhir Mattu, Marvell Semiconductor, Inc.Scott Crowder, BMC SoftwareBeth Boucher, SiriusPointDarrellFernandes, TIAAKristie Grinnell, GDITChrister Peltomaa, Comcast BusinessMike Goodwin, PetsmartSteve Mills,  iHeartMediaJacob Sorensen, Bank of the WestPaul Algreen, Janus HendersonMichael Mathews, DeluxeAshok Vantipalli, TireHubSumit Anand, At HomeTodd Renaud, Conn's HomePlusJohn Hill, Business PlanningCarharttUsmanWaheed, KnollJames Chilton, Cengage LearningMatt Bieri, Tyler TechnologiesDawn KirchnerKing, Armstrong World IndustriesMichael Salas, SUEZBernieGracy, AgeroDave Hoag, OCCWendy Pfeiffer, Nutanix, Inc.Joan Kuehl, Elevate Credit, Inc.Pramesh Naik, Troutman PepperJason White, Berkshire BankAndrew Brock, AssociaTarek Tomes, Minnesota IT ServicesRavi Pendse, University of MichiganTanya Hannah, King County, WA Bob Solis, MIT Lincoln LaboratoryKevin Boyd, University of ChicagoLen Peters, NYUMatt Chambers, Baylor, Scott and White HealthRusty Yeager, Encompass HealthCraig Richardville, SCL HEALTHTom Gordon, Virtua HealthLisa Dykstra, Ann & Robert H. Lurie Children's Hospital of ChicagoMike Larson, Agiliti Health, Inc.Host: Evan McLaughlin, evanm@inspirecio.com,National Executive Director: Evan McLaughlin, evanm@inspirecio.com

We're going backward. Instead of climbing out of the pit of the pandemic, the U.S. is seeing a new surge. The highly contagious COVID-19 delta variant is causing new infections, new hospitalizations and new deaths — almost exclusively among the unvaccinated. Centers for Disease Control and Prevention Director Rochelle Walensky said last week that cases are up more than 70 percent from the previous week. Deaths, a lagging indicator, have increased 26 percent. In almost every instance, it's the unvaccinated getting sick and dying from the virus. The good news? Vaccines work. The bad news? The U.S. needs more people to get vaccinated. And trying to convince the remaining hesitant will not be a fast or easy job. What does this mean for breakthrough infections? Will cases continue to rise, and will mask mandates go back into place, as they already have in Los Angeles County? And what about kids — especially those 12 and under who aren't yet eligible to be vaccinated? Do they face another year of wearing masks in the classroom? Kerri Miller tackled those topics and more Wednesday morning with two doctors who are on the front lines of pandemic research. Guests: Dr. Monica Gandhi is a professor of medicine and associate division chief of the Division of HIV, Infectious Diseases and Global Medicine at UCSF/San Francisco General Hospital.  Dr. Tina Tan is a professor of pediatrics at the Feinberg School of Medicine at Northwestern University and an attending physician at Ann & Robert H. Lurie Children's Hospital in Chicago. To listen to the full conversation you can use the audio player above. Subscribe to the MPR News with Kerri Miller podcast on: Apple Podcasts, Google Podcasts, Spotify or RSS

For years, the role of development operations teams has been perceived as a data and technology-focused position within the nonprofit world. As technology, nonprofits, and the way we fundraise has significantly changed over the last few decades, so has the role of the operations team. For organizations and leaders willing to evolve, this presents an incredible opportunity – both for the organization's success and the individual's advancement. In today's episode, Deb Taft, CEO of Lindauer and Luis Morales, senior director of information strategy at Ann & Robert H. Lurie Children's Hospital of Chicago, chat with guest host Ashley Sweeney of Blackbaud about the ways that today's DBAs are adding value to the organization, how leaders can maximize this impact, and what operations team members should do to advance their career.   Topics Discussed in This Episode: The value that operational teams offer healthcare organizations How leaders in the organization play a key role in the operation team's value Cross-functional teams Why DBA is an important and interesting area to work right now The different types of people needed to work in the area Why you need to develop communication and relationship skills How to think about diversity in donor and prospect pools The evolution and opportunity of the role   Resources: Deb Taft Luis Morales Promoting Your Value as a Database Administrator Confessions of a Database Administrator Confessions of a Database Administrator, Part II Ashley's Favorite Things   Quotes:  “The value I see the operations team offering is collaboratively ensuring that our clients, their colleagues, have the context they need to make strategic data-driven decisions.” “The value of the operations team is different and differently valued than it was years ago as a profound driver really of nonprofits and advancement results.” “The operations team can create value by enriching conversations.” “It's about more than just filling requests and mailing lists and reports. We are the subject matter experts for the organization's data, integrations, trends, etc.” “I encourage my team to work as an internal consulting company with different business units in the foundation are our clients.”

Protests in the summer of 2020 raged on in most major cities for weeks protesting the death of George Floyd, police brutality, and in support of black lives. All of these are incredibly heavy and complex topics to discuss with children, so where do you begin?Protests in the summer of 2020 raged on in most major cities for weeks protesting the death of George Floyd, police brutality, and in support of black lives. All of these are incredibly heavy and complex topics to discuss with children, so where do you begin?In this encore episode from last summer, Dr. Nia Heard-Garris joined Melanie Cole, MS, to help parents discuss this moment in history with our kids. Dr. Heard-Garris is a pediatrician and a researcher in the Department of Pediatrics at Feinberg School of Medicine at Northwestern University; and also in the Division of Academic General Pediatrics and Mary Ann & J. Milburn Smith Child Health Research, Outreach, and Advocacy Center at the Ann & Robert H. Lurie Children's Hospital of Chicago.

Protests in the summer of 2020 raged on in most major cities for weeks protesting the death of George Floyd, police brutality, and in support of black lives. All of these are incredibly heavy and complex topics to discuss with children, so where do you begin?Protests in the summer of 2020 raged on in most major cities for weeks protesting the death of George Floyd, police brutality, and in support of black lives. All of these are incredibly heavy and complex topics to discuss with children, so where do you begin?In this encore episode from last summer, Dr. Nia Heard-Garris joined Melanie Cole, MS, to help parents discuss this moment in history with our kids. Dr. Heard-Garris is a pediatrician and a researcher in the Department of Pediatrics at Feinberg School of Medicine at Northwestern University; and also in the Division of Academic General Pediatrics and Mary Ann & J. Milburn Smith Child Health Research, Outreach, and Advocacy Center at the Ann & Robert H. Lurie Children's Hospital of Chicago.

Anthony Yang, MD, MS, FACS, Chair of the SSO Endocrine Disease Site Work Group is joined by fellow Workgroup Members, Mark Cohen, MD, FACS, FSSO and Cord Sturgeon, MD, MS, FACS, along with Samuel Hyde, CGC. This episode is the first of a two-part series.  The expert panel will discuss the incidence, prevalence, and epidemiology of primary hyperparathyroidism (PHPT).  They will review inherited syndromes associated with PHPT as well as when to send patients/families to genetic counseling for further evaluation and how to diagnose those syndromes.  Part two of our series will focus on the surgical management of hereditary forms of PHPT. Dr. Cohen is Professor of Surgery, Pharmacology and Biomedical Engineering; Vice Chair in Surgery for Clinical Operations; Director of the Center for Surgical Innovation; Director of the Medical School Pathway of Excellence in Innovation and Entrepreneurship; and Director of Endocrine Surgery Research at the University of Michigan. Dr. Sturgeon is Professor of Surgery, Chief of Endocrine Surgery at the Robert H. Lurie Comprehensive Cancer Center and the Director of Surgery at Northwestern Memorial Hospital.  Samuel Hyde is an ABGC-certified genetic counselor who specializes in hereditary cancer and is an instructor at the Northwestern University Feinberg School of Medicine.

Anthony Yang, MD, MS, FACS, Chair of the SSO Endocrine Disease Site Work Group is joined by fellow Workgroup Members, Mark Cohen, MD, FACS, FSSO and Cord Sturgeon, MD, MS, FACS, along with Samuel Hyde, CGC. This podcast is the second of a two-part series.  Whereas the first episode discussed an overview of primary hyperparathyroidism (PHPT) and the inherited syndromes associated with it, this episode will focus on the surgical management of hereditary forms of PHPT, specifically multiple endocrine neoplasia syndromes types 1 & 2 (MEN1 & MEN2). Dr. Cohen is Professor of Surgery, Pharmacology and Biomedical Engineering; Vice Chair in Surgery for Clinical Operations; Director of the Center for Surgical Innovation; Director of the Medical School Pathway of Excellence in Innovation and Entrepreneurship; and Director of Endocrine Surgery Research at the University of Michigan. Dr. Sturgeon is Professor of Surgery, Chief of Endocrine Surgery at the Robert H. Lurie Comprehensive Cancer Center and the Director of Surgery at Northwestern Memorial Hospital.  Samuel Hyde is an ABGC-certified genetic counselor who specializes in hereditary cancer and is an instructor at the Northwestern University Feinberg School of Medicine.

About Dr. Timothy Pearman Dr. Timothy Pearman is a Psychologist at Lurie Cancer Center at Northwestern Medicine. He is a board-certified clinical health psychologist, a Fellow of the American Academy of Clinical Health Psychology (ACHP) and Director of the Supportive Oncology program at the Robert H. Lurie Comprehensive Cancer Center. Dr. Pearman has served […]

About Dr. Timothy Pearman Dr. Timothy Pearman is a Psychologist at Lurie Cancer Center at Northwestern Medicine. He is a board-certified clinical health psychologist, a Fellow of the American Academy of Clinical Health Psychology (ACHP) and Director of the Supportive Oncology program at the Robert H. Lurie Comprehensive Cancer Center. Dr. Pearman has served […] The post TMBS E176: Dr Pearman – Psychologist appeared first on Business RadioX ®.

In the cover paper of this week's issue of Oncotarget (Volume 12, Issue 10), titled, "Inhibitory effects of Tomivosertib in acute myeloid leukemia," researchers based out of Chicago, Illinois, U.S., from Northwestern University’s Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, and Jesse Brown Veterans Affairs Medical Center conducted a new study to assess the efficacy of Tomivosertib to regulate the eIF4E binding protein in AML. In this study, the researchers purchased Tomivosertib (and Venetoclax) from TargetMol. They cultured AML cell lines, used clonogenic leukemic progenitor assays in methylcellulose, cell viability assays, cell lysis and immunoblotting, co-immunoprecipitation assays, plasmids and transfections, and conducted proteomics immunoprecipitation analysis using liquid-chromatography-tandem mass spectrometry, gene annotation and protein function enrichment analysis, and statistical analysis. “We demonstrate that Tomivosertib suppresses eIF4E phosphorylation in AML cells and decreases leukemic cell survival and proliferation.” Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.27952 DOI - https://doi.org/10.18632/oncotarget.27952 Full text - https://www.oncotarget.com/article/27952/text/ Correspondence to - Leonidas C. Platanias - l-platanias@northwestern.edu Keywords - MNK, Tomivosertib, acute myeloid leukemia, eIF4E About Oncotarget Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology. To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget YouTube - https://www.youtube.com/c/OncotargetYouTube/ LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

As the CEO of 1871, an entrepreneurial hub of innovation, Betsy Ziegler is an expert in early-stage growth and helps businesses grow from idea to the Fortune 500. For Betsy, one of the most important metrics for success is whether a business adheres to purpose-driven decision making. This week on Innovation and the Digital Enterprise, Betsy joins Patrick and Shelli to discuss how 1871 is supporting businesses throughout Chicago as well as what metrics she believes will help catapult businesses to higher levels of growth. Listen in for her insights. (01:10) - The home for start-ups (04:33) - Does it work? (06:46) - Launch outside of gravity (10:09) - Forty by forty (14:23) - Purpose, ideas, and the maturity curve (23:09) - Talking about change (27:15) - Onboarding and mentorship (38:48) - First dollar https://www.linkedin.com/in/betsy-ziegler-14237b/ (Elizabeth “Betsy” Ziegler) is the first female CEO of 1871, the number 1 private incubator in the world. Previous to 1871, Betsy was the Chief Innovation Officer at the Kellogg School of Management, Northwestern University, responsible for portfolio innovation as well as integrating technology into the Kellogg educational experience. From 2011 through September 2015, she served as associate dean of degree programs and dean of students. Prior to Kellogg, she served as a principal in McKinsey & Company’s Chicago office where she led the firm’s Life Insurance Operations and Technology practice and co-led its Financial Institutions Operations and Technology practice. Ziegler holds an M.B.A. from Harvard Business School and received a B.A. in economics from The Ohio State University, where she graduated with distinction. She is a member of Ann & Robert H. Lurie Children's Hospital of Chicago, and the Museum of Science and Industry Boards of Directors and an advisor and investor in many young technology companies. If you'd like to receive new episodes as they're published, please subscribe to Innovation and the Digital Enterprise in https://podcasts.apple.com/us/podcast/innovation-and-the-digital-enterprise/id1451753709?mt=2 (Apple Podcasts), https://podcasts.google.com/?feed=aHR0cHM6Ly9mZWVkcy50cmFuc2lzdG9yLmZtL2lubm92YXRpb24tYW5kLXRoZS1kaWdpdGFsLWVudGVycHJpc2U%3D (Google Podcasts), https://open.spotify.com/show/3fOSh73F3sjyK7TIMFSOc1?si=uRAeLNvjQjmbnFjzWIvMlg (Spotify) or wherever you get your podcasts. If you enjoyed this episode, please consider leaving a review in https://podcasts.apple.com/us/podcast/innovation-and-the-digital-enterprise/id1451753709?mt=2 (Apple Podcasts). It really helps others find the show. https://www.dante32.com/ (Podcast episode production by Dante32.)

Jyoti Patel, MD, is the medical director of thoracic oncology and assistant director for clinical research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. In this episode of the Better Edge Podcast, she discusses emerging treatments for lung cancer, including the introduction of seven new therapies approved by the FDA this year. She shares how treatment of lung cancer has evolved to become more personalized with both biologic and immunotherapy options and how new therapies will continue to shape the standard of care for lung cancer.

This episode features Scott Wilkerson, Senior Vice President & Chief Integration and Business Development Officer at Ann & Robert H. Lurie Children's Hospital of Chicago. Here, he discusses his current top priorities, his focus on children's preventive care, and more.

This episode features Scott Wilkerson, Senior Vice President & Chief Integration and Business Development Officer at Ann & Robert H. Lurie Children’s Hospital of Chicago. Here, he discusses his current top priorities, his focus on children’s preventive care, and more.

In this episode of the Better Edge Podcast, Jane Winter, MD, professor of Medicine in the Division of Hematology and Oncology and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, discusses results from recent study published in the journal Blood. Findings showed that a brief course of immunotherapy resulted in complete and near complete remission in nearly two-thirds of previously untreated patients with classical Hodgkin lymphoma.

Ann & Robert H. Lurie Children’s Hospital Vice President Jenny Elhadary joins John Williams to explain the process of delivering and administering the COVID vaccines in her hospital.

Ann & Robert H. Lurie Children’s Hospital Vice President Jenny Elhadary joins John Williams to explain the process of delivering and administering the COVID vaccines in her hospital.

If oral and maxillofacial surgeons can find the time to commit to their local hospitals and associations beyond their private practices, the integrity of the specialty will be more securely protected. This is a belief held by today’s guest, Dr. Alexis Olsson, and his career shows it. Dr. Olsson is an Oral and Maxillofacial Surgeon practicing in Chicago, Illinois. He is currently Chief of Oral and Maxillofacial Surgery at Northwestern Memorial Hospital and Anne and Robert H. Lurie Children’s Hospital, as well as Professor of Clinical Otolaryngology and Head and Neck Surgery at Northwestern University Feinberg School of Medicine. He is also an active member in the oral and maxillofacial surgery community through his service to both AAOMS and well IAOMS. In this episode, we talk to Dr. Olsson about how he grew his practice to straddle the public and private spheres with such equal measure, while also hearing about as the techniques that have defined and are defining his practice today. We hear his thoughts on the current landscape of the oral and maxillofacial surgery specialty too, where he talks about the forces that are jeopardizing it, the need for new surgeons to take an active concern in its survival, and what is to be done in this regard. For a conversation rich in insights that span the technical and social sides of oral surgery, tune in today.Key Points From This Episode:Dr. Alexis Olsson’s education and career in both private and academic settings.How Dr. Olsson was able to grow his career in the academic as well as private space.Staying afloat in competitive downtown Chicago by being dedicated to patient care.The recent value of virtual surgical planning and new technology for Dr. Olsson’s practice.Challenges in Dr. Olsson’s career; less personal relationships between patients and doctors.Advice from Dr. Olsson for new surgeons who have a desire to protect the profession.Rewarding parts of being a teacher and Dr. Olsson’s hopes for his students’ futures.‘Taboo’ but effective techniques Dr. Olsson used early on and new tricks for optimizing surgery.How Dr. Olsson goes about doing implants generally – his case by case approach.When Dr. Olsson will do a flapless implant; biological characteristics of patients.Dr. Olsson’s philosophy of being conservative with soft tissue manipulation.The approach Dr. Olsson has to reconstructions and how things have become more aggressive.Dr. Olsson’s approach to doing molar immediate implants.What communication techniques and bedside manner should look like for surgeons.Final comments from Dr. Olsson about the need for oral and maxillofacial surgeons to protect their specialty and represent it well.Links Mentioned in Today’s Episode:Dr. Alexis OlssonNorthwestern UniversityNorthwestern Memorial HospitalLurie Children’s HospitalNorthwestern MedicineNorthwestern University Feinberg School of MedicineNorthwestern Dental CenterAAOMSIAOMSDr. Mark C. HuttenDr. Grant Stucki Contact — 720-775-5843

Hear from the experts in our conversations on a rare, hereditary disorder: Galactosemia. We cover Galactosemia diagnosis, new treatment options, and how to connect with the Galactosemia community. Experts in this episode include: *Judith Fridovich-Keil PhD: Principal investigator in the Fridovich-Keil lab at Emory University. *Anne Kozek, MS, RD, LDN: Registered dietitian at the Ann & Robert H. Lurie Children's Hospital of Chicago. * Brittany Cudzilo: Outreach Coordinator for the Galactosemia Foundation, and mother of three daughters, the youngest of which has Classic Galactosemia. More resources and information for you: raredisease.com/galactosemia

In this episode of Better Edge, Anna Strohl, MD, assistant professor in the Division of Gynecologic Oncology and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, discusses how surgical innovations have improved patient outcomes and safety for the treatment of gynecologic cancers.Related: Northwestern Medicine John I. Brewer Trophoblastic Disease Center is one of only two centers in the country dedicated to the treatment of gestational trophoblastic diseases (GTD). Anna Strohl, MD shares how the establishment of the center has led to nearly one hundred percent cure rates and the development of the first-ever NCCN national care guidelines for GTD in a video.

Register for this week's COVID-19 Provider Town Hall! Live Q&A with the Children's Colorado pediatric infectious disease team and updated epidemiology of the pandemic : https://register.gotowebinar.com/register/7276255001809281037  Hospitals and pediatric practices are under increasing pressure to be publicly transparent about their quality and safety outcomes. The rapid growth of quality improvement initiatives and surgical outcomes in pediatric heart care has made national news headlines in recent years, demonstrating the correlation between pediatric heart surgical volumes and outcomes for kids. On today’s episode we are going to discuss outcomes transparency in pediatric heart care and the work that one nonprofit has done to lead the way in data transparency. Today we are fortunate to be joined by David Kasnic, Executive Director for the non-profit, Conquering CHD. 15 Participating Centers AdventHealth for Children – Orlando, FL Advocate Children’s Hospital – Oak Lawn, IL Ann & Robert H. Lurie Children’s Hospital – Chicago, IL Children’s Healthcare of Atlanta – Atlanta, GA Children’s Hospital Colorado – Aurora, CO Children’s Hospital Los Angeles, Los Angeles, CA Children’s National – Washington, DC Children’s Wisconsin – Milwaukee, WI Cincinnati Children’s Hospital – Cincinnati, OH Medical University of South Carolina – Charleston, SC Nationwide Children’s Hospital – Columbus, OH New York Presbyterian Hospital – Columbia – Cornell – New York, NY Seattle Children’s Hospital – Seattle, WA University of California at Davis Health – Sacramento, CA University of Michigan Congenital Heart Center – Ann Arbor, MI   How to Get Involved: Patients and Families Visit the Hospital Navigator launch blog at conqueringchd.org/hospital-navigator-launch Check the list of participating centers Use the Patient and Family Advocacy Toolkit to talk to your center about joining   How to Get Involved: Providers/Hospitals Visit the Hospital Navigator launch blog at conqueringchd.org/hospital-navigator-launch Download the invitation letter and submission form Send questions to Rebeka Acosta, Education Coordinator, at racosta@conqueringchd.org  Do you have thoughts about today's episode or suggestions for a future topic? Write to us, chartingpediatrics@childrenscolorado.org 

Endometrial cancer is the most common gynecologic cancer in North America. When detected early, it has very good survival outcomes. But when the cancer spreads outside of the uterus and into the lymph nodes, this cancer can become more deadly and cause a higher rate of re-occurrence. Edward Tanner, MD, chief of gynecologic oncology at Northwestern Medicine and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, discusses the use of sentinel lymph node (SNL) mapping to diagnose and treat endometrial cancer.

Dr. Ravi Jhaveri, MD, Associate Division Head of Pediatric Infectious Diseases at the Ann & Robert H. Lurie Children's Hospital of Chicago and Professor of Pediatrics at Northwestern University Feinberg School of Medicine discusses how parents can prepare their families for this year’s flu season, while navigating alongside a global pandemic.

Dr. Ravi Jhaveri, MD, Associate Division Head of Pediatric Infectious Diseases at the & Robert H. Lurie children’s hospital of Chicago and Pediatrics Professor at Northwestern University Feinberg School of Medicine, joined AM Tampa Bay to discuss the importance of getting your Flu Shot during the Covid-19 pandemic.

On this episode, co-host, Matthew Wellington, interviews Dr. Sameer Patel, pediatric infectious disease physician and Director of the Antimicrobial Stewardship Program at the Ann & Robert H. Lurie Children's Hospital of Chicago. In this episode, they discuss what it means to be an advocate and a health professional, and you will learn about Dr. Patel's experience working on health policy advocacy as a health professional and its importance especially in today's health climate.

Where the United States Postal Service Stands on Mail-In Ballots Come November As we move closer to November, we need to keep talking about what it looks like to vote during a pandemic. Blast Rocks Beirut on Tuesday Amid Mounting Tensions and Economic Turmoil At least 30 people were killed with thousands injured; hospitals were overwhelmed by the number of injuries. Why Are So Many Golden Age Rappers Dying Young? There is a troubling pattern of rappers that came to fame during the late 80s and 90s dying in their 30s and 40s. Activists See Progress in Fight to Halt Surgeries for Intersex Children Last week, the Ann and Robert H. Lurie Children's Hospital of Chicago became the first major hospital in the country to officially halt genital surgeries for intersex children.   For transcripts, see individual segment pages.

Where the United States Postal Service Stands on Mail-In Ballots Come November As we move closer to November, we need to keep talking about what it looks like to vote during a pandemic. Blast Rocks Beirut on Tuesday Amid Mounting Tensions and Economic Turmoil At least 30 people were killed with thousands injured; hospitals were overwhelmed by the number of injuries. Why Are So Many Golden Age Rappers Dying Young? There is a troubling pattern of rappers that came to fame during the late 80s and 90s dying in their 30s and 40s. Activists See Progress in Fight to Halt Surgeries for Intersex Children Last week, the Ann and Robert H. Lurie Children's Hospital of Chicago became the first major hospital in the country to officially halt genital surgeries for intersex children.   For transcripts, see individual segment pages.

En el debate de reapertura de escuelas en algunos países del mundo, uno de los temas de conversación gira en torno a si los niños propagan o no el coronavirus. En este episodio, el doctor Elmer Huerta habla de un estudio publicado en la revista médica JAMA Pediatrics y elaborado por doctores del hospital Ann & Robert H. Lurie Children’s Hospital de Chicago y de la escuela de Medicina de la Northwestern University. En la investigación, los doctores estudiaron la carga viral de coronavirus en niños y adolescentes entre 5 a 17 años y adultos entre 18 a 65 años. Para conocer sobre cómo CNN protege la privacidad de su audiencia, visite CNN.com/privacidad

In the second of our two-part series on race, racism, and health, we have a discussion with pediatrician and researcher Dr. Nia Heard-Garris on talking to kids and loved ones about racism: why it’s important, how to maintain momentum, and (if you haven't already) where on earth to start. You may recognize her from the recent CNN/Sesame Street Town Hall on racism, so we'll get her recommendations for anti-racist resources for kids and adults alike.Dr. Nia Heard-Garris, MD, MSc is a pediatrician and physician-investigator at the Ann & Robert H. Lurie Children’s Hospital of Chicago and in the Department of Pediatrics at Northwestern University Feinberg School of Medicine. She examines the influence of social adversities, including the impact of racism on subsequent child and adolescent health. Dr. Heard-Garris is also interested in the factors that contribute to a child’s ability to thrive despite these experiences. In August 2019, she received her career development award (K01), which is funded by the National Heart Lung and Blood Institute, and with this award she plans to investigate adolescent cardiometabolic health. She believes in using research to better inform clinical practice and policy that supports children, their families, and their communities. Dr. Heard-Garris is also an active member of the American Academy of Pediatrics (AAP) and serves as the Chair and founding member of the Provisional Section of Minority Health, Equity, and Inclusion. Dr. Heard-Garris completed a prestigious Robert Wood Johnson Foundation Clinical Scholars Fellowship at the University of Michigan. She earned her Master of Science in Health and Healthcare Research. She received her Doctor of Medicine (MD) from Howard University College of Medicine and helped to launch the student-run free clinic serving DC residents. Dr. Heard-Garris earned her Bachelor of Science in biology at Spelman College in Atlanta, Georgia. She lives with her husband and 6-year-old son in Chicago.

Episode 11 Today I interview my absolute most FAVORITE person on the entire face of the planet, Doctor Emily Roben. She is an emergency room attending at Lurie Childrens Hospital, she was a field hockey goalie at Stanford University (on a scholarship!), she is an incredible artist and crafter, and she is the best wife and best friend a person could ask for.www.whatcanyoutellme.cominstagram @whatcanyoutellmefacebook @whatcanyoutellmetwitter @whatcanutellmehttps://www.instagram.com/ranchoroben/https://www.instagram.com/craftastic613/Born in Exeter, NH. Moved to Cupertino, CA and spent many years of her youth attending an extra curricular Hebrew school program ultimately having her Bat Mitzvah at age 13.Began playing field hockey as a goalie at Monta Vista High School.Entered freshman year at Stanford University playing field hockey on a scholarship.Notable students and faculty while she was at Stanford include numerous Olympic and professional athletes, Chelsea Clinton and Ben Savage from Boy Meets World, (BTW Rider Strong played Shawn Hunter on that show)https://www.imdb.com/title/tt0105958/Jered Diamond author Guns Germs and Steel https://amzn.to/2Tef13CRobert Sapolsky author Why Zebras Dont Get Ulcers https://amzn.to/2y75VyiSan Jose State for premed also had the fun of taking raquet ball, kickboxing and bowling Currently playing pickle ball with mehttps://amzn.to/3g06Gu7Attended Northwestern University Medical School. Started pediatrics residency at Childrens Memorial Hospital in Chicago which became Ann and Robert H. Lurie Childrens Hospital. Fellowship in pediatric emergency medicine at Ann and Robert H. Lurie Childrens Hospital. Became an attending physician in the emergency department at Ann and Robert H. Lurie Childrens Hospital https://www.luriechildrens.org/not to be confused withChildrens Hospital (COMEDY TV SHOW)https://www.imdb.com/title/tt1325113/SouthLAnd (COP SHOW)https://www.imdb.com/title/tt1299368/?ref_=fn_al_tt_1Discussions about what work can be likeBegan learning to crochet and made a 3D anatomicaly correct heart. Has won multiple awards from the National Arts Program. (Picture of heart is here!) https://www.nationalartsprogram.org/nap-spotlight/emily-robenRaises animals in the backyard farm-currently 6 chickens, a duck, 2 goats, a lovebird, 2 pet rats and a salt water aquarium. Check out Emily's instagram account with all of the animals https://www.instagram.com/ranchoroben/“There's lots of reasons to become a doctor but money is a very bad one.”Favorite food as a kid- steamed Artichoke dipped in butterFavorite beverage- carbonated wateror her invented cocktail The Best in Show- gin, soda, grenadine, limeHates Karaoke and especially HATES the B-52's (which I LOVE to sing)Podcast Likes-Experts on Expert with Dax ShepherdSerial By the Book Radio Lab FreakonomicsApple Music Playlists- Barefoot Acoustic, Todays CountryIs an incredibly dedicated cyclist who rides a bike 300+ days a year (in Chicago) to work (12 miles round trip) 

A different kind of episode this week. After hearing from Touretters on the Tourette's Podcast Answering Machine, we talk Tourette science and medicine with one of the best -- Dr. John Walkup, Chair of the Pritzker Department of Psychiatry and Behavioral Health at the Ann & Robert H. Lurie Children's Hospital in Chicago, Illinois. We get his backstory, how he wandered into Tourette as a focus, and then we cover the most frequently asked question submitted to Tourette's Podcast -- what's the lowdown on marijuana as a Tourette treatment? Valid? Problematic? Needs work? Let's circle up and learn. In the second half of the episode, we talk anxiety science -- what's going on in our brains when we feel it? What's the use of it? Where can we take it? Hugely thankful to have Dr. Walkup guide us through. Tourette's Podcast is made possible with the support of the Tourette Association of America. Dr. John Walkup  Tourette Association of America (give your support!)  TAA position on medical marijuana  Virtual Conference May 15 and 16  Virtual Quilt  Geeks Rising 

In this episode, we listen in as KT’s homie, Dhwanil chats with Dr. Taylor Heald-Sargent about the current coronavirus pandemic. Taylor is currently a third-year Pediatric Infectious Disease fellow at Ann & Robert H. Lurie Children’s Hospital of Chicago. She is also an expert virologist with interest in the coronaviruses and she has a PhD looking at human coronavirus entry. Taylor and Dhwanil have a great discussion about the initial SARS epidemic from the early 2000s and the lessons we learned from it. They also break down the current pandemic, including where coronaviruses come from and what sorts of illnesses they cause, why children seem to be spared from serious illness during this pandemic and why health care workers seem to have higher rates of serious illness. They also talk treatment strategies currently being studied such as convalescent plasma therapy and cover the concept of herd immunity within a population. To the healthcare professionals on the frontline that are probably either getting off of a shift or getting ready for their next, thank you for all that you do! Slide in our DMs and gives us your two cents: MRx Facebook MRx Instagram MRx Twitter #CarpeDM Hit up Taylor and Dhwanil directly: Taylor's Twitter Dhwanil's IG --- Send in a voice message: https://anchor.fm/medicineremixed/message

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has rapidly evolved to develop new protocols and a Coronavirus Disease 2019 (COVID-19) response team to ensure the safe and effective treatment for cancer patients during the COVID-19 pandemic. In this episode, Leonidas C. Platanias, MD, PhD, director of the Lurie Cancer Center of Northwestern University, explains the protocols in place to minimize risk, and how the team is safely delivering critical treatment and providing emotional support for patients during this time.

Dr Carolyn Lam:               Welcome to Circulation on the Run, your weekly podcast soiree and backstage pass to the journal and its editors. I'm Dr Carolyn Lam, Associate Editor for the National Heart Center and Duke National University of Singapore. Dr Greg Hundley:            And I'm Greg Hundley, Associate Editor from the Pauley Heart Center at VCU Health in Richmond, Virginia. Well, Carolyn, this week we're going to talk about carotid stenosis, and you remember how we measure those a lot with ultrasound, and what that thickness is, and IMT? Well, we're going to talk about getting some thresholds and an update in that with our feature discussion today. But before we get there, how about grab a cup of coffee and we get started with other papers. Dr Carolyn Lam:               All right. Well, I've got my coffee and I'm ready to tell you about two papers. They're both on left ventricular hypertrophy. One is basic and one is clinical. I will start with the basic paper because it is a super cool one that uncovers a novel mechanism underlying myocardial hypertrophy. And this involves S-nitrosylation, a prototypic, redux-based post-translational modification, S-nitrosylation. So this is from co-corresponding authors, Drs Xie, Han, and Ji from Nanjing Medical University, who performed a series of elegant experiments using myocardial samples from patients and animal models exhibiting myocardial hypertrophy, and they demonstrated that S-nitrosylation of muscle limb protein plays a crucial role in myocardial hypertrophy. This muscle limb protein modification enhanced binding to toll-like receptor 3 and receptor interacting protein kinase 3, which stimulated NOD-like receptor pyrin domain containing 3 or NLRP3 inflammasome activation and consequent caspace-1 and interleukin 1 beta activation, ultimately promoting myocardial hypertrophy. They further showed that the deficiency of S-nitrosylated muscle limb protein governed toll-like receptor 3 really alleviates pathological myocardial hypertrophy. Okay Greg, I can see the look on your face. You're like what? That was a lot. What are the clinical implications, right? Dr Greg Hundley:            Yeah, Carolyn, you are taking me back to molecular biology course 410, that I would take as a senior in college. Wow. So tell me what are the clinical implications? Dr Carolyn Lam:               All right, here's a take-home. The data really identify that S-nitrosylated muscle limb protein is a key regulator, which together with toll-like receptor 3 made therefore serve as putative therapeutic targets in treating pathological myocardial hypertrophy in heart failure. That's the take-home. Before any further comments, let's go to the clinical study. Now, this one focuses on a malignant subphenotype of left ventricular hypertrophy in which minimal elevations of cardiac biomarkers identify individuals with left ventricular hypertrophy at high risk for developing heart failure. And this is from corresponding author Dr James de Lemos from UT Southwestern. He and his colleagues tested the hypothesis that a higher prevalence of the malignant left ventricular hypertrophy phenotype among blacks may contribute to racial disparities in heart failure risk. So they pooled data from three large multi-ethnic cohorts, that is Eric, Dallas Heart Study, and MESA, totaling more than 15,700 participants. These participants were then classified into three groups: One, those without ECG left ventricular hypertrophy; two, those with ECG left ventricular hypertrophy but normal biomarkers; and three, those with ECG left ventricular hypertrophy and at normal levels of two biomarkers, high sensitivity troponin T above six nanogram per liters, or NT-proBNP above 100 picograms per milliliter. And that last group were the malignant left ventricular hypertrophy group. They found that the prevalence of malignant left ventricular hypertrophy was threefold higher among black men and women versus white men and women. Compared to participants without left ventricular hypertrophy, the adjusted hazard ratio for heart failure was 2.8 in those with malignant ventricular hypertrophy and only 0.9 in those with left ventricular hypertrophy and normal biomarkers. And these were similar findings in each race and sex subgroups. Mediation analysis indicated that 33% of the access hazard of heart failure among black men and 11% of the excess hazard among black women was explained by the higher prevalence of malignant left ventricular hypertrophy in blacks. Dr Greg Hundley:            So Carolyn, race could be a really important issue in left ventricular hypertrophy. What did the authors conclude? I mean, how should this help us perhaps manage these patients? What was the take-home? Dr Carolyn Lam:               So this really shows that a higher prevalence of the malignant hypertrophy phenotype may in part, explain the higher risk of heart failure among blacks compared to whites. And what it means too is that when left ventricle hypertrophy is detected by ECG or cardiac imaging, perhaps we should consider measuring high sensitive troponin T or NT-proBNP, which will help distinguish those in whom risk for heart failure is favorable from those at a much higher risk. Dr Greg Hundley:            Very, very interesting. Well Carolyn, I'm going to switch. I've got a basic paper and it's going to focus on dysfunctional adipocytes and how they might talk to cardiomyocytes in the situation of ischemia reperfusion injury. And the corresponding author is Xin-Liang Ma, from Thomas Jefferson University in Pennsylvania. So Carolyn, do you have any thoughts regarding how patients with diabetes might experience a greater degree of myocardial ischemia reperfusion injury in the setting of an MI? Dr Carolyn Lam:               Oh my goodness, you're really putting me on this spot here. Well, I know things that come to mind would be oxidative stress, microvascular disease. Dr Greg Hundley:            Very good. Open-ended questions for Carolyn's quiz. I'm going to give you a 90. That was very good. So Carolyn, this current study attempted to clarify whether and how small extracellular vesicles may mediate pathological communication between diabetic adipocytes and cardiomyocytes, exacerbating myocardial ischemia reperfusion injury. And to do this, adult male mice were fed a normal or high fat diet for 12 weeks. The small extracellular vesicles from diabetic serum, diabetic adipocytes, high glucose, high lipid-challenged, non-diabetic adipocytes were injected then, intramyocardially, distal of the site of a coronary ligation. Dr Carolyn Lam:               Okay. So Greg, I would not have guessed it was about extracellular vesicles, but very interesting. What did they find? Dr Greg Hundley:            Intramyocardial injection of diabetic serum small extracellular vesicles or these SEVs, in the nondiabetic heart, significantly exacerbated myocardial ischemia reperfusion injury, as evidenced by poor cardiac function recovery, larger infarct size, and greater cardiomyocyte apoptosis. And administration of small extracellular vesicles, biogenesis inhibitors, significantly mitigated the myocardial ischemia reperfusion injury in diabetic mice. And mechanistic investigations in these studies identified that MIR 130B3P is a common molecule, significantly increased in diabetic serum of small extracellular vesicles and mediated the pathological communication between the dysfunctional adipocytes and the cardiomyocytes. Therefore, if in the future, we could interfere with this molecule, that could perhaps be a novel strategy for attenuating diabetic exacerbation of myocardial ischemia reperfusion injury. Really, a clever study, I think. What else did you find in this issue of the journal? Dr Carolyn Lam:               Yeah, Greg, this week's issue is packed with other papers too. For example, there's the research priorities for HFpEF by NHLBI working group summary by Dr Shah, et al. There's a research letter by Dr Kaltman on the disparities in congenital heart disease mortality based on proximity to a specialized pediatric cardiac center. There's also another research letter by Dr Irisawa, on the impact of low-flow duration on favorable neurological outcomes of extracorporeal CPR, after out-of-hospital cardiac arrest, and this is a multicenter prospective study. Dr Greg Hundley:            It sounds like a lot's in the mailbag. In the couple of things that I wanted to talk about, Dr Giulia Rivasi from the University of Florence, and William White from University of Connecticut, exchange a series of letters back and forth regarding a previous publication on the effects of intensive versus standard ambulatory blood pressure control on cerebrovascular outcomes in older individuals. I have another research letter entitled, The Cardiac Cell Therapy Rejuvenates the Infarcted Rodent Heart via Direct Injection, but not by Vascular Infusions. And that is from Dr Jeffrey Molkentin from Cincinnati Children's Hospital Medical Center. Finally, though Carolyn, there's a very interesting piece from Dr Carl Bakker at the Ann and Robert H. Lurie Children's Hospital of Chicago, discussing are we now in a time, in the United States, where congenital heart surgery should be coalesced or regionalized? And that really comes on the back of a discussion of there have been several high-profile articles in the national media, reporting on US congenital heart surgery programs. And that's led to, the author describes, some closure of several centers and at least in five programs. So a great discussion on, should this be regionalized? But we've got a great feature article coming ahead and how about if we head to that. Dr Carolyn Lam:               Let's go, Greg. Dr Greg Hundley:            Welcome everyone, to this feature discussion where we are going to discuss the use of diagnostic ultrasound in the carotid arteries and how that pertains to selection of patients for vascular surgery. And with us today, we have Dr Jesse Columbo from the Geisel School of Medicine at Dartmouth University in Hanover, New Hampshire. We also have Dr Bob Zwolak, from the Manchester VA at the Dartmouth School of Medicine and we have our own Josh Beckman from Vanderbilt University, one of our associate editors at Circulation. And Bob, let's get started with you. Could you tell us a little bit, what was the background of this study and what hypothesis were you looking to test? Dr Robert Zwolak:           It goes without saying that stroke is still a huge health problem in the United States. If there is any good news, it's that stroke incidence is falling slightly, but there are still over 100,000 deaths from stroke each year in United States and as many as 700,000 new strokes each year, and a significant proportion of those derive from atherosclerotic plaque in the carotid bifurcations. Carotid duplex ultrasound is a fantastic way to assess the presence of plaque in the carotid bifurcations because it does not use any ionizing radiation, does not require any contrast. Ultrasound is a relatively less expensive technology than CT or MR, and the study can be repeated so we can follow people over time, who are found to have significant atherosclerotic plaque in their bifurcations. The hypothesis of our study though, was that there is variation in the diagnostic thresholds used by various carotid ultrasound testing laboratories, such that it may impact the healthcare and the treatment plans of people who undergo the studies. Jesse will tell you the details, but specifically, we hypothesized that people who undergo this carotid ultrasound test may or may not be inducted into a surveillance program and intensive therapy based on the diagnostic criteria that were used by the individuals conducting their ultrasound study. And even more substantially, we hypothesized that individuals who undergo carotid endarterectomy or potentially carotid stenting, could also have their procedure influenced, whether or not they undergo surgery or stenting based on the carotid ultrasound results. It might vary from one facility to another. So it potentially could be that an individual would be inducted into ultrasound surveillance or even undergo carotid surgery, depending on the vascular laboratory in which they were tested. Dr Greg Hundley:            Jesse, could you tell us a little bit, what was your study population and how did you design this to address the hypothesis that Bob just stated? Dr Jesse Columbo:          Sure. A review of the published literature really shows a variability in that ultrasound criteria that's used for diagnosing carotid stenosis. And so our first objective was to see if we could obtain as many in-use criteria as possible. Our first step was to partner with the Intersocietal Accreditation Commission, the commission that accredits vascular labs. We partnered with them and obtained a 25% random sample of ultrasound criteria in use across the US. And so that kind of gave us the starting point for the criteria upon which to look at. We then wanted to apply those to a couple of different groups. As Dr Zwolak mentioned, there's really two primary breakpoints here. One, you either have mild stenosis, where you get medical therapy, but no further surveillance, or moderate stenosis, at which point you then are dedicated to long-term surveillance per the AAJ recommendations, or then, the break point between moderate and severe stenosis where surgery is considered. What we wanted to do is examine the impact of moderate and severe stenosis thresholds. For the severe stenosis thresholds, we use the Vascular Quality Initiative Registry, which collects information on patients who underwent carotid endarterectomy. When we studied patients specifically that we thought the percent stenosis would be the major deciding factor in who got surgery, those are the asymptomatic stenosis and we applied the range of severe stenosis criteria from the IAC to those patients. We then wanted to study other individuals who might be committed to long-term surveillance based on the criteria used. And so for that, we used participants in the Cardiovascular Health Study, which had their induction into the study, had baseline data on carotid stenosis collected. And so that kind of formed our basis of the study, applying the criteria to those two different groups of individuals. Dr Greg Hundley:            And so how many subjects did you have in the two cohorts? And then tell us what were your study results? Dr Jesse Columbo:          Sure. Once we narrowed down that patients in the vascular quality initiative to those who underwent surgery for asymptomatic carotid stenosis, we had about 28,000 patients. And then when we examined the Cardiovascular Health Study, we had about 4,800 or 5,000 patients in that group. What we found was pretty interesting. If you look at individuals who underwent surgery, and you take the carotid threshold criteria and apply it to them, and if you say, "Well, we're going to take criteria in the fifth percentile versus criteria in the 95th percentile," what you'll find is that 10% of patients who got surgery, fall between that range. And what that means is that there are patients, approximately 10% of patients, who are undergoing surgery that may not have been offered surgery if they had gone to a different institution, which we thought a pretty important finding. The second part was studying patients who maybe committed to long-term surveillance. And if we took centers that were in the fifth percentile versus those in the 95th percentile for their carotid stenosis thresholds, we found a twofold difference in the number of patients that would be committed to long-term surveillance. And remember, this is the difference between getting aspirin and a statin and medical therapy, but no longer surveillance and getting carotid ultrasound every six months to a year for a long period of time. That twofold difference really could have a meaningful impact on patients. Dr Greg Hundley:            It sounds like we've got a variance issue here and that could really impact clinical care. So while ultrasound's very portable and advantageous, how do we use these results to more effectively select how we're going to implement ultrasound to monitor these patients? Dr Joshua Beckman:       I have to say the results of this study, when I read them the first time were eye opening. One point that doesn't come out clearly to those folks who aren't necessarily in the field, is that these are the labs that have been accredited and they are the top labs in the United States. This doesn't include at least half of the rest of the labs in the United States and suggest that if there's variation in the very best of labs, you know that there's even more variation that's being practiced routinely around the United States. So when I read this, I thought that there was a huge problem that they were uncovering. There are many, many millions of patients with atherosclerosis. And so what we have to figure out now is how to standardize the measurement and reading of these studies so that ultrasound can be deployed routinely, without a fear of your treatment varying based on which doctor you decide to see and where you decided to go. And I think the fact that these guys highlighted that in such a nice and clear way, really raises the alarm and raises the flag that attention needs to be paid here quite soon because it's quite important. Dr Greg Hundley:            So what study could we perform next? And maybe I'll ask, Bob, you just start off. What study could we perform next to help clarify and guide us to the better use of ultrasound in this situation? Dr Robert Zwolak:           Well, I think there are two issues. The first issue that this manuscript points out is the one of variation and it's real and the results speak for themselves. The second issue is the one of accuracy, and the question of what are the best thresholds? And there are several ways that this can be standardized. I'm pleased to say that the Intersocietal Accreditation Commission, the IAC, that Jesse mentioned, is actually tackling this problem. Dr Robert Zwolak:           But what's the gold standard? 40 years ago when ultrasound was developed, these thresholds that people are discussing, were related to measurements on contrast arteriograms. And the catheter-based contrast arteriogram, a relatively invasive study, was the source and we compared ultrasound velocities to the measurements on the contrast arteriograms to determine these thresholds that Jesse has investigated. That resulted in substantial variation depending on the individual authors. The question is, over time, have the machines changed? Is there really a central focus that we can look at? Most of these studies were very small and so it accounts for the variation in recommendations. Dr Robert Zwolak:           The IAC now, is going back and collecting contemporary contrast arteriograms, not so many of which are done anymore and so, it's taken a very substantial multicenter effort. But trying to look again, to see if there are more accurate results that could be published, studied in a way such that they would be universally accepted and potentially promulgated by professional societies within guidelines. And standardized such that various specialties, whether it's vascular surgeons who run the labs, or a cardiologist, or radiologist, would agree on a set of both accurate and reproducible and constant velocity thresholds to standardize this technology, which is otherwise a very, very good technology and eliminate this variation that we've seen. Dr Greg Hundley:            Well, this has been a phenomenal discussion in a very interesting piece of research. Jesse, can you give us sort of a point forward from here, how do we move forward with some of these results and what you anticipate seeing going forward? Dr Jesse Columbo:          Well, a duplex ultrasound for carotid stenosis is really important. There are lots of studies done. It's a great way to follow patients over time, in a noninvasive manner. And I might hope that this paper would open the eyes of some of the listeners as to what the carotid ultrasound really means. Instead of just looking at the percent stenosis on the report, to perhaps look at the raw velocities and interpret them in the context of the patient, because I think that has really important impact on how we might manage some of these individuals, for each person that you see. Dr Greg Hundley:            Well, listeners, we want to thank Dr Jesse Columbo, Dr Bob Zwolak, also Dr Josh Beckman, for discussing this very informative research related to the use of ultrasound for assessing carotid stenosis. Dr Greg Hundley:            On behalf of both Carolyn and myself, we wish you a great week and see you next week. This program is copyright, the American Heart Association 2020.  

Robert Leo Murphy, MD Northwestern Medicine joins Connected to Chicago. Dr. Murphy discusses in detail the Coronavirus, The local and global effects it is having on the world and the economy, and ways to prevent this disease from spreading. In this week's round table segment, John is joined by Ray Long of the Chicago Tribune, and Heather Cherone editor of The Daily Line. The conversation opens up with coverage of the Coronavirus scare, and then it’s off to the upcoming Super Tuesday. Could Biden take South Carolina? Or is it up to Bernie? The Chicago Board of Education voted this week to not celebrate Columbus Day anymore, and now call it Indigenous Peoples Day. This week's Connected to Chicago feature segment is with Nick Gale. It focuses on a new collaborative initiative to help communities on the West Side of Chicago. Mayor Lori Lightfoot joined leaders from the American Medical Association and West Side United to announce $6 million in private sector investments for community improvements on the West Side. West Side United will allocate the funds as low-interest loans to local businesses for economic development projects, health care initiatives and quality-of-life improvements. The West Side United collaborative is comprised of six Chicago hospitals, including Rush University Medical Center, Ann & Robert H. Lurie Children's Hospital of Chicago, AMITA Health, Cook County Health, Sinai Health System, and University of Illinois Hospital & Health Sciences System. The mayor has said she is committed to redeveloping the South and West sides and pointed to the millions of dollars that have already been pledged by private businesses, in addition to the new investment announced Wednesday, as an example of how success breeds success.

Esophageal cancer is the fastest growing malignancy in the United States that often has no symptoms in its early stages. David Odell, MD, associate professor of Thoracic Surgery at Northwestern Medicine and the Robert H. Lurie Comprehensive Cancer Center at Northwestern University, specializes in minimally invasive treatment of esophageal cancer. Tune in to hear him share more about Northwestern Medicine's comprehensive approach to treating esophageal cancer, the latest technology and his team's work to development of protocols for early detection.

Cleaning with disabilities comes up from time to time. People wonder can those with Down syndrome clean? Angela Brown, The House Cleaning Guru says yes. Those with Down syndrome want to be a contributing member of society. They want to give something back and help others in spite of their disabilities. Development delays shouldn't stop anyone who wants to clean from house cleaning. Today's #AskaHouseCleaner sponsors are Savvy Cleaner Training for house cleaners and maids. *** MOST REQUESTED LIST OF CLEANING STUFF I USE *** https://www.Amazon.com/shop/AngelaBrown *** MORE VIDEOS ON THIS TOPIC *** The Truth About Down Syndrome - Children’s Hospital Colorado - https://youtu.be/CcFjzUazsB4 Down Syndrome: Attitudes and Expectations - Boston Children's Hospital - https://youtu.be/l5R1ReVi2XQ Down Syndrome: Occupational Therapy Demonstration - Ann & Robert H. Lurie Children's Hospital of Chicago - https://youtu.be/Rz4wbdeqIPM How I Do my Household Chores in my Wheelchair - Laundry & Kitchen - Wheelsonheels - Gem Hubbard - https://youtu.be/ptGSecisMao Disabled people's life hacks: tips for clever adaptations around the home - Equality and Human Rights Commission - https://youtu.be/4j8nyslXeP0 *** GOOD KARMA RESOURCES FROM THIS EPISODE *** These good karma links connect you to Amazon.com and affiliated sites that offer products or services that relate to today’s show. Organizing Solutions for People with ADHD - https://amzn.to/37xLqrn The Queen of Distraction: How Women with ADHD Can Conquer Chaos, Find Focus, and Get More Done - https://amzn.to/2KQrnL5 Supporting Positive Behavior in Children and Teens with Down Syndrome: The Respond but Don't React Method - https://amzn.to/2shwldz The Parent's Guide to Down Syndrome: Advice, Information, Inspiration, and Support for Raising Your Child from Diagnosis through Adulthood - https://amzn.to/2QOyOWX Mental Wellness in Adults with Down Syndrome: A Guide to Emotional and Behavioral Strengths and Challenges - https://amzn.to/2KQCMKP *** OTHER WAYS TO ENJOY THIS SHOW *** ITUNES - http://apple.co/2xhxnoj STITCHER - http://bit.ly/2fcm5JM SOUNDCLOUD - http://bit.ly/2xpRgLH GOOGLE PLAY - http://bit.ly/2fdkQd7 YOUTUBE - https://goo.gl/UCs92v *** GOT A QUESTION FOR A SHOW? *** Email it to Angela[at]AskaHouseCleaner.com Voice Mail: Click on the blue button at https://askahousecleaner.com *** HOUSE CLEANING TIPS VAULT *** (DELIVERED VIA EMAIL) - https://savvycleaner.com/tips *** FREE EBOOK – HOW TO START YOUR OWN HOUSE CLEANING COMPANY *** http://amzn.to/2xUAF3Z *** PROFESSIONAL HOUSE CLEANERS PRIVATE FACEBOOK GROUP *** https://www.facebook.com/groups/ProfessionalHouseCleaners/ *** VRBO AIRBNB CLEANING FACEBOOK GROUP *** https://www.facebook.com/groups/VRBO.Airbnb.Cleaning/ *** LOOKING FOR WAY TO GET MORE CLEANING LEADS *** https://housecleaning360.com *** WHAT IS ASK A HOUSE CLEANER? *** Ask a House Cleaner is a daily show where you get to ask your house cleaning questions and we provide answers. Learn how to clean. How to start a cleaning business. Marketing and Advertising tips for your cleaning service. How to find top quality house cleaners, housekeepers, and maids. Employee motivation tactics. Strategies to boost your cleaning clientele. Cleaning company expansion help. Time-saving Hacks for DIY cleaners and more. Hosted by Angela Brown, 25-year house cleaning expert and founder of Savvy Cleaner Training for House Cleaners and Maids. *** SPONSORSHIPS & BRANDS *** We do work with sponsors and brands. If you are interested in working with us and you have a product or service that is cohesive to the cleaning industry read this: https://savvycleaner.com/product-review *** THIS SHOW WAS SPONSORED BY *** SAVVY CLEANER - House Cleaner Training and Certification – https://savvycleaner.com MY CLEANING CONNECTION – Your hub for all things cleaning – https://mycleaningconnection.com HOUSECLEANING360.COM – Connecting House Cleaners with Homeowners – https://housecleaning360.com SAVVY PERKS – Employee Benefits for Small Business Owners – https://savvyperks.com VRBO AIRBNB CLEANING – Cleaning tips and strategies for your short-term rental https://TurnoverCleaningTips.com

Men with inflammatory bowel disease have four to five times higher risk of being diagnosed with prostate cancer, according to a 20-year study from Northwestern Medicine published in the journal European Urology.Shilajit Kundu, MD, chief of Urologic Oncology and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University discusses the link between prostate cancer and inflammatory bowel disease. He shares Northwestern Medicine's approach to screening, diagnosing and treating this unique combination of conditions.

Lung cancer is the second most common cancer and is the leading cause of cancer death in men and women. Ankit Bharat, MD, chief of Thoracic Surgery and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, discusses the latest advances in lung cancer treatment, and when it is important to refer to the specialists at Northwestern Medicine. He discusses how Northwestern Medicine team is using innovative research to prevent, treat, and manage lung cancer.

According to the American Cancer Society, rates of melanoma have been rising rapidly over the past few decades with an estimated 96,480 cases diagnosed in 2019 alone. Joining me today is Dr. Jeffrey Wayne, chief of Surgical Oncology at Northwestern Medicine and the associate director for clinical affairs at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University. Dr. Wayne is here today to share the latest advances and treatment of melanoma.

Guest: Johnathan Strauss, MD Recorded live at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, Dr. Jonathan Strauss, an Associate Professor of Radiation Oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, shares key strategies for delivering targeted radiotherapy to avoid damaging associated tissues.

Guest: Johnathan Strauss, MD Recorded live at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, Dr. Jonathan Strauss, an Associate Professor of Radiation Oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, shares key strategies for delivering targeted radiotherapy to avoid damaging associated tissues.

Guest: Johnathan Strauss, MD Recorded live at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, Dr. Jonathan Strauss, an Associate Professor of Radiation Oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, shares key strategies for delivering targeted radiotherapy to avoid damaging associated tissues.

Guest: Johnathan Strauss, MD Recorded live at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, Dr. Jonathan Strauss, an Associate Professor of Radiation Oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, shares key strategies for delivering targeted radiotherapy to avoid damaging associated tissues.

In the United States, there are an estimated 72,570 new cases of bladder cancer each year. The Northwestern Medicine Department of Urology evaluates and manages each patient with emphasis on an integrated, multidisciplinary and stage-specific approach. Our team is committed to conducting innovative research to increase our understanding of the biology of bladder cancer and identifying new therapies and technologies for bladder cancer in order to improve quality of life for our patients.Joshua Meeks, MD, PhD, assistant professor of Urology and a member Robert H. Lurie Comprehensive Cancer Center of Northwestern University, of the joins the show to shares how his team of scientists are involved in three active trials focused on genetic and epigenetic changes in bladder cancer, as well as immuno-oncology in bladder cancer.

Those who experience both parental incarceration and juvenile justice involvement as children were nearly three times more likely to have depression or post-traumatic stress disorder (PTSD) compared to peers without any experience with the criminal justice system, according to a study published in JAMA Network Open.  Read the Pediatric Research News summary here.  PRN had the opportunity to sit down with the study's lead author, Nia Heard-Garris, MD, MSc, a pediatrician at Ann & Robert H. Lurie Children's hospital of Chicago. We discussed how the idea for this study originated, the importance of physicians recognizing the scope and impact of parental incarceration and juvenile justice involvement, and what changes she would like to see in the support networks available to these children and young adults.   

On Episode 16 of All Ears at Child's Voice: A Hearing Loss Podcast, Tatum and Wendy interview Dr. Nancy Young, an otolaryngologist and cochlear-implant surgeon at Ann & Robert H. Lurie Children's Hospital of Chicago. Dr. Young shares about her experience as a cochlear-implant surgeon, the changes she's witnessed in the cochlear implant surgery and hearing loss field over the course of her career, and the research she's involved with at Lurie Children's Hospital. - Find us @childs_voice, @tatumfritzSLP, @wendydetersSLP, @ms_elise_sunshine. Email us at podcast@childsvoice.org. Follow along with the transcript and find show notes at childsvoice.org/podcast. - [Child's Voice is a listening and spoken language program for children with hearing loss. Views expressed on the show, both by the guests and by the hosts, may not necessarily represent the views of Child's Voice.]

Will Ulaszek (Chairman of Little Heroes League) joins Dane Neal to discuss the incredible organization of Little Heroes League.  Inspired by the journey of their granddaughter Livia, Kim and Will Ulaszek founded a charity, Little Heroes League, an Affiliated Organization of Ann & Robert H. Lurie Children’s Hospital of Chicago, to help babies born with […]

Dr. Pennell and Dr. Kircher discuss the push for increased price transparency among stakeholders in an effort to control the rising costs of healthcare. Read the related article on ascopubs.org.   TRANSCRIPT: Welcome to the latest Journal of Oncology Practice podcast, brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content and offering enriching insight into the world of cancer care. You can find all recordings, including this one, at podcast.asco.org. My name is Dr. Nate Pennell, medical oncologist at the Cleveland Clinic and consultant editor for the JOP. Americans are very familiar with comparison shopping for goods and services based on the price. I can buy anything from a car or a television to life insurance to hiring a contractor to remodel my home. And I could expect that the price of that good or service is going to be easily available. It's going to be accurate. And then I can compare it to their competitors prices. So I can then make my decision based on that price and the quality of the goods or services. But what if you wanted to shop around for your health care? How easily can we determine the true out-of-pocket costs for, say, a hip replacement or a screening colonoscopy? In truth, I bet aside from a purely cosmetic procedure, most people don't ever recall being told what the price is of a medical procedure before having it done. So why is medicine different? And how does this impact the cost of health care? And what can we do to improve price transparency? With me today to discuss this issue is Dr. Sheetal Kircher, associate professor and GI medical oncologist at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Dr. Kircher is a member of the ASCO Health Equity Committee and was a recent ASCO Health Policy Fellow from 2018 to 2019. We'll be discussing her paper, "The opaque results of federal price transparency rules and state-based alternatives", to be published in the August, 2019 JOP. Welcome Dr. Kircher, and thanks for joining me today. Thanks for having me. So first of all, can you briefly kind of review why aren't health care costs like other goods and services? And why isn't it easy to understand and compare between them? There's a lot of reasons that health care costs are really just fundamentally different than really almost any other goods or services that I can think of. Taking your example of shopping for a TV, when you know which TV you want, you to go to multiple stores. You check to see if there's free online shipping. And you choose the lowest price. Even if you don't know what TV you want, you can see what the cost is going to be. And this cost is going to be inclusive of tax, shipping. And you can even see what that cost will be if you had a coupon or promo code. In addition to the cost of these TVs, we will see ratings, hundreds, thousands of people with commentaries on their experience with that exact product. So many times, you could even return it. So as we can see, health care is just really different. The stakes are higher. So even when we use this word, cost, shopping around for health care, and things like that, already that kind of seems like a misnomer. For the individual case and the actual cost of a service, it's complicated. It's difficult to figure out because almost nobody pays what we think of as like the list price. The literal list price for hospitals is called a charge master. A charge master is really just the list prices out the gate that a hospital comes up with and becomes a starting point for negotiation for payers. And then each plan will have a different contracted rate for that service. And this is problematic, isn't it? Because the charge master is sort of the-- when people start, at least say with the federal regulations, that's the price that they're sort of trying to get people to put out there. But that's not necessarily all that helpful. Exactly. And you know, in addition, because there's such variation in what the patient will actually pay at the end of the day after their insurance coverage kicks in, when you look at the hospital list of prices, it's difficult, even for myself with a medical degree, to understand what I'm looking at. For example, if I'm thinking of a single service, like a colonoscopy, there could be many components to a colonoscopy, such as the doctor fee, facility fee, pathologist, anesthesiologist. So even if you saw the word colonoscopy on one of these lists, it's impossible to really know if that's inclusive of all the components of that procedure. So say a patient was able to actually get a hold of these contracted rates instead of the lowest prices. And then they were able to know all the components of that service. They would still need to understand the specific cost sharing details of their insurance plan, such as like how much the deductible is, what's their copay, what's their coinsurance. In my experience, and I think it's well-published in the literature, that most patients even struggle to just know what the definition of those things are, like your deductible, let alone what their actual amounts are. You know, it does sound complicated. And obviously, I think a lot of doctors are familiar with the multiple different charges and whatnot. But at the same time, given the complexity of modern technology and whatnot it doesn't sound to me undoable for a particular hospital to bundle all of the costs of a single procedure together and to somehow link to what your insurance company should cover for that kind of thing. It does not seem to me like this is an undoable technological fix if someone wanted to do it. I agree. There's been a lot of attempts, both at the state level and federal, to really address this issue. I mean, even taking a step back even further, institutions have tried to, at least for their patients, provide more accurate down at the patient level estimates of their costs. And as simple as it sounds, it is actually quite difficult. And the reasons are because a lot of people contracting from payers as well as insurance it still is very opaque, even in people that are highly skilled and trying to figure this out. So if you are an actual patient, I mean, I think that the challenges just become even greater. But some states have taken some more kind of in the weeds active approach to improve price transparency in health care as a whole, including oncology. [INAUDIBLE] states have implemented or at least passed laws where they create something called an all-payer claims data set or APCDs. What these are it's still a list of prices. I think it tackles some of these issues that we just talked about, because what these lists are, they account for the negotiated price, as opposed to the pre-negotiation charge master. So basically, it's the price after the coupon. You know, it's like the real price. Most of these data sets, or at least many of them, have incorporated quality metrics. Now, I would have to say that the quality metrics between states is all over the map. Nobody has agreed on these quality metrics. But it's at least one more tool to help the patient in addition to cost to make decisions. I think a kind of interesting point this all brought up as we were doing this work is almost like a bigger question of do patients want to comparison shop for their health care. So I mean, if my primary care doctor, who I trust and I know, and I've known for 15 years, recommends a procedure, so say a colonoscopy, I'm likely to choose the doctor and the facility that she recommends. I don't even remember if you go to get a procedure, they usually don't even tell you ahead of time what the cost is and ask you if that's something you're interested in paying. Usually you just schedule it, and you do it. And you get a bill after the fact. That would have to be a pretty big shift in the culture of how we approach paying for health care if we were going to start comparison shopping. You'd have to understand that you needed to do that to begin with. You'd have to know how to do it and how to compare these things. It's certainly not undoable. It's something, again, that we do for almost every single other thing that we buy, but it would require quite a major change. Absolutely. And there's an even larger price transparency kind of movement going on. In relation to we were just saying about a patient-- say an oncology patient is starting chemotherapy. Federally, there's multiple different efforts that are trying to improve price transparency. So the oncology care model, one of the 13 kind of pillars of that care plan, one of them is delivering out-of-pocket costs before treatment starts. Now, in oncology specifically, this is problematic and very challenging. You know, kind of trust me, we've tried. And we continue to try because when you think of the drugs we give oral chemotherapy, targeted agents, and then IV chemotherapy, we're not only dealing with totally different modes of treatment. We're talking about different payment structures of how cost sharing works. So typically, IV chemotherapy is on our hospital outpatient benefits, while oral chemotherapy is covered by our prescription drugs. Now, both of those, in say Medicare for example, are completely different cost sharing structures. So the experience for a patient picking up their oral chemotherapy is at essentially a retail pharmacy or if it's perhaps a specialty pharmacy. But there's a cash register. And you're paying for it there. The experience of paying for your IV chemotherapy is just like you described with the procedure, where you get it done. You get the bill at home. And just the experience alone is really different. So federally, for this specific charge master display, so as of January 1st, all hospitals must publicly display their charge master. You know, like I said, these were never intended for consumer viewing. So they were first mandated to exist in the actually the Affordable Care Act. And the Trump Administration has really built upon this and said, why make patients ask for the charge master. How about we just require the hospitals to publicly display these? So that's where this kind of mandate came through. It's interesting because as we went through this exercise in the publication, and the codes they use, the abbreviations, even with a medical degree, I had a hard time deciphering what they said. Yeah, it does seem as though a lot of hospitals did not take this as a mandate to try to make this a transparent and useful thing. They said, well, the requirement is we're going to put it up. And here's our Excel spreadsheet or our PDF with all of the jargonese there. And you can do with it what you will. Absolutely. And I wasn't surprised when we saw that even within four months of this being mandated, 88% of the hospitals we looked at in Chicago had it published. They were right on it. They had published it. And it was on their website. Because the ACA had already required that they have it. So really, they just took it out of the file folder and put it on the website without much thought that they were trying to make it helpful for patients. A lot of disclaimer that a lot of, I think, hospitals overall did a really good job of putting kind of the fine print on there and saying that please speak to your doctor and facility to actually get the real cost. So I think the hospitals overall did a pretty good job of that. As you and your authors point out, if someone actually did try to use that information to comparison shop, or what I would think perhaps would be more common, they would look it up just to see what the price is going to be forwardly placed they've been told they're supposed to go. They might see a $3,000 charge for their CT, which might have been completely covered by their insurance with no out-of-pocket expense to them at all and decide not to get it because they're afraid they're going to be charged $3,000. Right. So in the hopes of having this transparent playing field, my major concern is even I, if I saw that amount of money, maybe that would make me pause a little bit actually. And I think the last thing we need to do, especially in these screening tests that there is no shortage of data saying that they improve survival. I want my patients to get them. There's enough barriers, I think, to getting someone a colonoscopy, that I would hate for that to be an unintended consequence of showing people the cost, especially in this inaccurate kind of forum. So what can we do about this? What do you and your co-authors recommend to try to address cost transparency moving forward? I think it's exciting that there is momentum here. I mean, I think price transparency, although has become a buzz word, it is going to continue to be an active issue at the state and federal levels. What makes this exciting to me is that it is bipartisan. So we all care about health care, to a different degree, and we all have different strategies. But I do feel that this is a bigger discussion about transparency, not only here at the patient level, provider level, hospital level even. I really think I hope we're moving to a place where there is a bigger discussion of transparency at all levels. I'm talking even starting up at the manufacturer level. But from a very practical patient level standpoint, we all encourage people to develop APCDs. There's interesting results that have been shown in some states that there is a good way to show people cost. And by doing so, programs, such as California's program, has actually shown that utilization of lower priced facilities has increased. And most importantly is that when patients are shown a cost and have some sort of way to impact or influence the amount of cost sharing that they will have based on their decision making, there is an opportunity perhaps for patients to choose lower cost facilities. Now, even as I'm saying this out loud, my first concern and worry is making sure that outcomes are the same. And so I, first and foremost, care about complication rates for surgery and things of that nature. But there are state level programs that have shown that we can have both. It can be a dominant solution. So I encourage states to especially have the flexibility to accommodate variations in state level health care markets, the states is really where these databases belong. And they should take it the next step further to make them interpretable, inclusive of all cost. And I encourage states and federally to work together to say if we're getting a colonoscopy, that includes services A, B, C, and D. So when patients are comparing, they're actually comparing apples to apples. Evidence-based standardized quality metrics incorporated into these cost models will help us at least keep thinking about getting to this ultimate goal of value. And it's like hard not to plug when we're talking about cost and everything is this concept of value. And making sure that no matter what structure we choose to show people cost to have it impact their out-of-pocket cost sharing, those services as we have deemed in the evidence to be high value, the screening lung CT, the colonoscopy, really should be at a minimal cost sharing for patients, no matter what sort of structure that we have. No, that makes perfect sense. One of the things that jumped out here, if you actually have data that using an APCD increase the number of patients moving to lower priced facilities from here, you mentioned from 68% up to 90%, the first thing that would occur to me is that that might actually end up driving down prices from competition, which is something that has never been a successful strategy in medical care for some reason. Absolutely. The specific program I'm talking about from California is called CalPERS. And it's the government 1.3 million state employee programs. And really, the premise of that program is so interesting because it's the assumption that we can never really decrease the cost of care unless individual consumers are aware of the prices and have some sort of input into their cost sharing and decision making. Oh, yeah. This is everybody is looking for ways to reduce costs. And when you see success like this, you'd think people would jump all over this. You'd think even hospitals and health systems would want to market that they have lower costs procedures to get more business. It's just very interesting that this is flying so under the radar. Absolutely. And I do think, though, that there are more and more states actually jumping on board. So I'm hopeful in the next five, 10 years that as the real discussion of the value and value based care continue, this will really, I hope, will become more common. And Dr. Kircher, thanks so much for joining me on the podcast. Thank you for allowing me to discuss the paper. Until next time, thank you for listening to this Journal of Oncology Practice podcast. If you enjoyed what you heard today, don't forget to give us a rating or a review on Apple Podcasts or wherever you listen. While you're there, be sure to subscribe so you never miss an episode. JOP's podcasts are just one of ASCO's many podcast programs. You can find all recordings at podcast.asco.org. And you can also find the full text of Dr. Kircher's paper online at ascopubs.org/journal/jop in August, 2019. This is Dr. Nathan Pennell for the Journal of Oncology Practice signing off.

Welcome to the first official Pediatric Research Now Podcast, an interview with Dr. Stacey Martiniano of Children's Hospital Colorado. She discusses recent research on the treatment of non-tuberculous mycobacterial infections in patients with cystic fibrosis. Check out PRN's summary of the study.   Pediatric Research Now highlights examples of the latest articles in pediatric research from around the United States and around the world. Our expert faculty at Ann & Robert H. Lurie Children’s Hospital translate the findings and publish easy-to-digest summaries for health professionals on the go. All content, including our newsletters, is cost-free.  The PRN Podcast takes things a step beyond and digs in to the stories behind the studies. We want to know the inspirations, the challenges, the unexpected outcomes and the future implications associated with recent journal publications... as told by the investigators themselves.

We know that your time is short. It can be difficult to keep up with the latest science focusing on children’s health, and to understand what you’re reading from across the full research spectrum. Brought to you by Ann & Robert H. Lurie Children's Hospital of Chicago, Pediatric Research Now is a new multi-channel tool that makes it easier for you. We pick great examples of the latest articles in pediatric research from around the United States and around the world. Our expert faculty at Lurie Children’s translate the findings for you. The PRN Podcast takes things a step beyond and digs in to the stories behind the studies. We want to know the inspirations, the challenges, the unexpected outcomes and the future implications associated with recent journal publications... as told by the investigators themselves. We designed PRN to be easy to access (no membership fee), easy to use (brief article summaries), and easy to share (through your favorite social media platforms). Sign up for our alerts, and we make sure that you will know when we feature another article or podcast. Why PRN, and why now? At Lurie Children’s, we want to celebrate high-quality research that focuses on children. We also want to make research accessible and understandable for anyone who wants to know more and learn more about kids’ health, today and tomorrow.

Developing physician leadership has long been a challenge for the healthcare industry. Physicians are often seen as leaders in a medical practice but many don't have the skills they need to reach their potential as leaders. Keith Olson is the Director of Physician Consulting Services at Ann & Robert H. Lurie Children’s Hospital of Chicago and is here to discuss steps to take to successfully develop physician leaders. Also in this episode, Barbara Sharpless, Director of Physician Services at BayCare Medical Group, discusses the current state of physician recruiting and retention. Barbara sheds light on the current state of the physician job market and explains the dynamics at play that gives physicians the leverage in the negotiation process. Finally, we talk to David Norris about financial intelligence for physicians. David is a practicing cardiac anesthesiologist in Wichita, KS, a consultant at David Norris, LLC, and author of the Financially Intelligent Physician: What They Didn’t Teach You in Medical School. He is also a clinical assistant professor at the University of Kansas in Wichita. David explains why business intelligence is important for physicians and outlines the three financial documents every doctor should understand. If you like the show, please rate and review it wherever you get your podcasts. Every review helps new listeners find the show. If you have any questions, concerns, or ideas, please shoot us an email at podcasts@mgma.com. MGMA Insights is presented by Craig Wiberg, Decklan McGee, and Daniel Williams. Announcement for podcast listeners: If you want to learn about or attend MGMA's live events, you can go to MGMA.com/events The next upcoming live event is The Data Conference, which will be May 16-18 in Orlando. You can learn more or register at mgma.com/datacon

Emilie Johnson, MD, MPH, is a pediatric urologist and health services researcher in Chicago, IL. She cares for pediatric urology patients (and their families) at Ann & Robert H. Lurie Children’s Hospital, and is an Assistant Professor of Urology at Northwestern University. In her practice, Dr. Johnson address the medical and surgical needs of children […]

Emilie Johnson, MD, MPH, is a pediatric urologist and health services researcher in Chicago, IL. She cares for pediatric urology patients (and their families) at Ann & Robert H. Lurie Children’s Hospital, and is an Assistant Professor of Urology at Northwestern University. In her practice, Dr. Johnson address the medical and surgical needs of children […]

In this episode of the Urology Care Podcast, we discuss talking with your doctor about Non-Metastatic CRPC treatment options with guest Dr. Edward "Ted" Schaeffer. Dr. Schaeffer is Chair of the Department of Urology at Feinberg School of Medicine and Program Director of the Genitourinary Oncology Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Today's Innovations in Medical Education (TIME) - The Electronic Educator Portfolio: A Tool to Enhance Learning and Assess Performance Tuesday, February 19* 4:00 p.m. to 5:00 p.m. Robert H. Lurie Medical Research Center Baldwin Auditorium 303 E. Superior St. Chicago, Illinois *Please note corrected date of event Robyn Ann Bockrath, MD Instructor of Pediatrics (Hospital-Based Medicine) Lindsay R. Koressel, MD Instructor of Pediatrics (Hospital-Based Medicine) Michael B. Spewak, MD Instructor of Pediatrics (Hospital-Based Medicine)

Maha Hussain, MD, FACP, FASCO, deputy director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University discusses this designation, that the latest advances in medicational the management of prostate cancer and how her work, that was recently published in the New England Journal of Medicine, will benefit men with aggressive states of prostate cancer.

What happens when local Latino students from underserved Chicago public high schools are given the opportunity to discover healthcare careers? Hear about the impact being made by a unique internship program at Lurie Children's Hospital of Chicago during our panel interview with Maria Rivera, LaDonna Alvarez and Jessica Saavedra from the hospital's Community Engagement and Workforce Education team! Learn more about the program here: https://www.luriechildrens.org/en/serving-the-community/advocacy/mentoring/

Srinadh Komanduri, MD, MS, professor of Medicine in the Division of Gastroenterology and Hepatology and a member Robert H. Lurie Comprehensive Cancer Center of Northwestern University discusses the link between heartburn and esophageal cancer. He shares the innovative research is being conducted in this area at Northwestern Medicine, where he stands as to implementing screening programs for esophageal cancer and how Northwestern Medicine and it's the Center for Esophageal Diseases play an important role in managing this disease.

Roughly, half of a million people worldwide will develop head and neck cancer on an annual basis. Sandeep Samant, MD, chief of Head and Neck Surgery and a member Robert H. Lurie Comprehensive Cancer Center of Northwestern University discusses the intricate nature of head and neck cancer, facial reconstruction and how it affects the daily lives of patients and their families. He shares the latest advancements in the treatment of head and neck cancer and how minimally invasive surgery, utilizing robotic and endoscopic techniques, are being used with great success at Northwestern Medicine.

With the population increasingly aging, the worldwide cancer burden is growing rapidly. Recognizing the need for more research on the diagnosis and treatment of geriatric cancer and survivorship care for older adults, June McKoy, MD, JD, MBA, associate professor of Medicine in the Division of Internal Medicine and Geriatrics and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, has dedicated her research and clinical work finding the best on cancer treatment and survivorship in older adults. In this episode, she discusses how comorbidities impact cancer treatment in older adults, alternative treatment options and the importance of coordinated care.

Maciej (Matt) S Lesniak, MD, chair of Neurological Surgery and program leader for Neuro-Oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, discusses the use of stem cells as a therapeutic approach for treating brain tumors, why he sees this as a breakthrough in this very unique clinical specialty and how Northwestern Medicine is leading the way in this cutting edge research.

Today's Innovations in Medical Education (TIME) Mixed Realities In Medical Education – Are We Ready? Tuesday, November 20 4:00 p.m. to 5:00 p.m. Robert H. Lurie Medical Research Center Baldwin Auditorium 303 E. Superior St. Chicago, Illinois Patricia M. Garcia, MD, MPH Associate Dean for Curriculum Professor of Obstetrics and Gynecology, and of Medical Education Northwestern University Feinberg School of Medicine Click here to RSVP for the lecture. Learning Objectives At the end of this presentation, participants will be able to: 1. Compare and contrast augmented and virtual reality. 2. Download and access some common AR/VR/MR applications. 3. Identify potential applications of AR/VR/MR in their learning environments.

Today's Innovations in Medical Education (TIME) Special Time Lecture: Implicit Race and Gender Bias in Healthcare Thursday, November 8th 4:00 p.m. to 5:00 p.m. Robert H. Lurie Medical Research Center Hughes Auditorium 303 E. Superior St. Chicago, Illinois

Today's Innovations in Medical Education (TIME) Special Time Lecture: Implicit Race and Gender Bias in Healthcare Thursday, November 8th 4:00 p.m. to 5:00 p.m. Robert H. Lurie Medical Research Center Hughes Auditorium 303 E. Superior St. Chicago, Illinois

Today's Innovations in Medical Education (TIME) Special Time Lecture: Implicit Race and Gender Bias in Healthcare Thursday, November 8th 4:00 p.m. to 5:00 p.m. Robert H. Lurie Medical Research Center Hughes Auditorium 303 E. Superior St. Chicago, Illinois

Today's Innovations in Medical Education (TIME) Making Phone Connections: Training and Assessing Interprofessional Communication via a Paging Module Tuesday, October 16 4:00 p.m. to 5:00 p.m. Robert H. Lurie Medical Research Center Baldwin Auditorium 303 E. Superior St. Chicago, Illinois Jennifer Trainor, MD Associate Chair for Education, Department of Pediatrics Associate Professor of Pediatrics and Medical Education Northwestern University Feinberg School of Medicine Division of Emergency Medicine Ann & Robert H. Lurie Children’s Hospital of Chicago Click here to RSVP for the lecture. Click here for more information and a schedule of upcoming TIME lectures. Learning Objectives At the end of this presentation, participants will be able to: 1. Discuss the Core Entrustable Professional Activities (EPAs) for entering residency. 2. Identify best practices in interprofessional communication and how they apply to medical student communication. 3. Identify key steps in the creation of an assessment for a communication-related EPA. Sponsored by the Feinberg Academy of Medical Educators. Credit Designation Statement Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Disclosure Statement Dr. Jennifer Trainor has nothing to disclose. Course director, Dr. Walter Eppich, has nothing to disclose. The Feinberg School of Medicine's Continuing Medical Education leadership and staff have nothing to disclose. Accreditation Statement The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Northwestern Medicine is proud to announce that Robert H. Lurie Comprehensive Cancer Center of Northwestern University has received the highest rating of Exceptional from the National Cancer Institute.Leo Gordon, MD, explains why this designation is so important for advancing cancer research that will then translate into new treatments for cancer patients.

Today's Innovations in Medical Education (TIME) Teaching Accurate Blood Pressure Measurement Across the Continuum of Medical Education Tuesday, August 21 4:00 p.m. to 5:00 p.m. Robert H. Lurie Medical Research Center Baldwin Auditorium 303 E. Superior St. Chicago, Illinois Michael Rakotz, MD, FAAFP, FAHA Vice President, Health Outcomes American Medical Association Assistant Clinical Professor of Family and Community Medicine Northwestern University Feinberg School of Medicine Kate Kirley, MD, MS Director of Chronic Disease Prevention, Improving Health Outcomes group American Medical Association Learning Objectives At the end of this presentation, participants will be able to: 1. Describe why accurate blood pressure measurements are important in hypertension diagnosis and management. 2. List the key steps to measuring blood pressure correctly and the implications of obtaining inaccurate readings. 3. Recognize educational gaps identified in medical students, residents and fellows when learning blood pressure measurement skills and retaining those skills over time. 4. Review educational needs for improving and sustaining blood pressure measurement skills. 5. Propose potential solutions to address educational gaps and needs to improve blood pressure measurement skills. Sponsored by the Feinberg Academy of Medical Educators. Credit Designation Statement Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Disclosure Statement Drs. Michael Rakotz and Kate Kirley have nothing to disclose. Course director, Dr. Walter Eppich, has nothing to disclose. The Feinberg School of Medicine's Continuing Medical Education leadership and staff have nothing to disclose. Accreditation Statement The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Power of Collective Wisdom: Effective Use of Clinical Competency Committees in UME and GME Tuesday, July 17 4:00 p.m. to 5:00 p.m. Robert H. Lurie Medical Research Center Baldwin Auditorium 303 E. Superior St. Chicago, Illinois Celia O’Brien, PhD Assistant Professor of Medical Education Northwestern University Feinberg School of Medicine Learning Objectives At the end of this presentation, participants will be able to: 1. Define purpose of clinical competency committees in UME and GME. 2. List features of effective group decision-making. 3. Compare and contrast the use of numeric ratings vs. narrative feedback in judging competency. 4. Discuss how social and professional judgements contribute to competency decisions. Sponsored by the Feinberg Academy of Medical Educators. Credit Designation Statement Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Disclosure Statement Dr. Celia O’Brien has nothing to disclose. Course director, Dr. Walter Eppich, has nothing to disclose. The Feinberg School of Medicine's Continuing Medical Education leadership and staff have nothing to disclose. Accreditation Statement The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Today's Innovations in Medical Education (TIME) TIME-ly Projects from the Medical Education Clinical Scholars (MECS) Program Tuesday, June 19 4:00 p.m. to 5:00 p.m. Robert H. Lurie Medical Research Center Baldwin Auditorium 303 E. Superior St. Chicago, Illinois Learning to be a doctor: Medical students' perception of their roles in longitudinal outpatient clerkships Blair Golden, MD Resident Physician, Internal Medicine Assessing ultrasound curriculums for critical care fellows: A single institution pilot study Rachel Kadar, MD Fellow, Critical Care Medicine Exposure and perception towards rehabilitation services for cancer patients among oncology subspecialty trainees Sonal Oza, MD Resident Physician, Physical Medicine and Rehabilitation Creating an endocrinology curriculum for general pediatrics residents Amy Rydin, MD Resident Physician, Pediatrics Learning Objectives At the end of this presentation, participants will be able to: 1. Introduce educational projects completed by McGaw trainees. 2. Demonstrate how educational projects serve as needs assessment for larger curricula. 3. Relate how educational projects during residency/fellowship translate into educational scholarship. Sponsored by the Feinberg Academy of Medical Educators. Credit Designation Statement Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Disclosure Statement Dr. Blair Golden, Dr. Rachel Kadar, Dr. Sonal Oza and Dr. Amy Rydin have nothing to disclose. Course director, Dr. Walter Eppich, has nothing to disclose. The Feinberg School of Medicine's Continuing Medical Education leadership and staff have nothing to disclose. Accreditation Statement The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

It's that time of the year again! This weekend, DePaul students will cram into the McGrath-Phillips Arena and stand for 24 hours to raise money for the sick kids at The Ann and Robert H. Lurie Children's Hospital. Radio DePaul will be in there with them, so this week we give you highlights from last year's DemonThon coverage.

Host: Prathima Setty, MD Disorders of sex development (DSDs) occur more frequently than most people realize, and yet there are numerous misconceptions persisting in the clinical arena as to how these disorders are best approached. For example, whereas older prevailing sentiments on presentations of ambiguous genitalia called for immediate sex assignments at birth followed by surgical alignments of those decisions, more modern philosophies advocate for direct patient involvement in these decisions a little later in life. Joining Dr. Prathima Setty to focus on this important topic is Dr. Earl Cheng, Professor of Urology, Division Head of Urology and Co-Head of Reconstructive Pediatric Urology at Northwestern University Feinberg School of Medicine. Dr. Cheng directs the Gender and Sex Development Program at Ann & Robert H. Lurie Children's Hospital of Chicago.

Every year since 2011, DemonThon has been putting on an annual 24-hour dance marathon to benefit the Ann and Robert H. Lurie Children's Hospital in Chicago. Radio DePaul has had the proud opportunity to partner with this great organization for the past 3 years. This episode is entirely dedicated to DemonThons past and present.

"HSP 90 inhibitors are a really cool class of drugs..." states Dr. Melissa Johnson of the Robert H. Lurie Comprehensive Cancer Center as she describes what researchers are learning about these drugs still in early development. February 2014.

"HSP 90 inhibitors are a really cool class of drugs..." states Dr. Melissa Johnson of the Robert H. Lurie Comprehensive Cancer Center as she describes what researchers are learning about these drugs still in early development. February 2014.

"HSP 90 inhibitors are a really cool class of drugs..." states Dr. Melissa Johnson of the Robert H. Lurie Comprehensive Cancer Center as she describes what researchers are learning about these drugs still in early development. February 2014.

Join us as we talk with Dr. Jonathan Licht of the Robert H. Lurie Comprehensive Cancer Center and Northwestern University about high risk myeloma. 

What are the risks of attempting to get pregnant after cancer? Should you try? How long should you wait. What is the risk to the child and mother. Host Dawn Davenport will interview two of the leading experts in the US on Pregnancy after Cancer: Dr. Jacqueline Jeruss, a breast surgeon and the Oncofertility Consortium's Clinical Co-Director of Oncology and an Assistant Professor within the Department of Surgery and a member of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University; and Dr. Nicole Noyes, Reproductive Endocrinologist with NYU Fertility Center, Professor and the Director of Reproductive Surgery at the New York University School of Medicine and Medical Center, President of the ASRM Special Interest Group on Fertility Preservation.   Blog summary of the show and highlights can be found here:  Blog summary of the show  Highlights   More Creating a Family resources on donor insemination can be found here.Support the show (https://creatingafamily.org/donation/)

Guest: Seth Corey, MD, MPH Host: Bruce Bloom, DDS, JD Physician scientists keep one foot in clinical care and the other in the lab, hoping to bridge that gap to help patients. Are breakthroughs on the horizon? Dr. Seth Corey, the Sharon Murphy and Steven Rosen Professor of Cancer Biology and Chemotherapy at Northwestern University Feinberg School of Medicine and director of oncology research at Children's Memorial Hospital and the Robert H. Lurie Comprehensive Cancer Center, joins host Dr. Bruce Bloom to discuss his research on repurposing safe pharmaceutical and botanical medicines for relapsed pediatric cancers.

Guest: Bruce Komiske, MHA Host: Bruce Japsen As if finding treatments and cures for diseases and injuries of children was not a big enough of a challenge for researchers, try your hand at building a facility to meet tomorrow's needs for specialized pediatric care. Bruce Komiske, chief of hospital design and construction at the Ann and Robert H. Lurie Children's Hospital of Chicago, tells host Bruce Japsen about the complex and rewarding challenges involved in planning and building new pediatric facilities.